Sanofi-Aventis ADR SNY

… pharmaceuticals companies in the U.S. Using the example of Pfizer along with Merck ( MRK ) , Novartis AG ( NVS ) and Sanofi ( SNY ) , will be enough to prove to you why this industry holds the key to a healthy portfolio. Brief Analytical Review of Pfizer …

By Rajiv Tarigopula : Johnson & Johnson ( JNJ ) , one of the world's leaders in the pharmaceutical, medical devices, and general consumer products industries, is a supreme opportunity for long-term value investors. Trading near $63 today, Johnson & Johnson has a very healthy dividend yield of over

By James Stocklasar Thomas Jr. : Here is Zalicus ( ZLCS ) at a discount. Recent 12 Month Low $0.72/share closing at $0.77/share (18 May 2012) Breaking its previous mid-80 cent low, Zalicus has fallen, but on the heels of ZERO negative news. Zalicus has simply fallen because the market is bearish.

By Mel Daris : Sanofi ( SNY ) has not reported a lot of good news lately. The company plans to shut down a plant in Newcastle, and a drug that it has been …

… IR ); M&T Bank Corp ( MTB ); Mastercard ( MA ); Moody's Corp ( MCO ); Procter & Gamble ( PG ); Sanofi-Aventis ( SNY ); Torchmark Corp ( TMK ); US Bancorp ( USB ); USG Corp ( USG ); United Parcel Service ( UPS ); Wal-Mart Stores ( WMT …

By Stock Croc : Recent discoveries have placed Eli Lilly ( LLY ) in the spotlight for colluding with India's drug regulators. Eli Lilly, along with other Big Pharma names such as GlaxoSmithKline ( GSK ) and Novartis ( NVS ) , has been colluding with Indian drug regulators to speed up approval ...

By Stock Croc : Recently, Pfizer ( PFE ) attempted to survive the patent expiration of Lipitor by spending enormous amounts of money on marketing the drug, although cheaper alternatives are now available. This is an interesting move on the drug company's part as I feel that the strategy of pumping